首页 | 本学科首页   官方微博 | 高级检索  
     

补骨脂素抑制膀胱癌T24细胞增殖和迁移的作用及机制研究
引用本文:翁铭芳,刘容,魏俊杰,林琴,孙星慧,王栋,吴卫真. 补骨脂素抑制膀胱癌T24细胞增殖和迁移的作用及机制研究[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(4): 193-199. DOI: 10.3877/cma.j.issn.2095-1221.2022.04.001
作者姓名:翁铭芳  刘容  魏俊杰  林琴  孙星慧  王栋  吴卫真
作者单位:1. 350025 福州,中国人民解放军联勤保障部队第九〇〇医院泌尿外科2. 350025 福州,福建医科大学福总临床医学院泌尿外科
基金项目:联勤保障部队第九〇〇医院2019年度医院科研计划项目(2019Q01)
摘    要:目的探讨补骨脂素对人膀胱癌T24细胞存活率、细胞周期、细胞凋亡和迁移的影响及其分子机制。 方法分别用细胞培养液、3‰二甲基亚砜(DMSO)和不同浓度(10、30、50、100 μg/mL)补骨脂素处理膀胱癌细胞分成对照组、DMSO组和补骨脂素组,CCK-8检测细胞存活率。流式细胞术检测细胞周期和细胞凋亡。划痕实验检测划痕愈合率。RT-qPCR法检测磷脂酰肌醇3激酶(PI3K)和蛋白激酶B (AKT) mRNA表达水平、Western blot法检测PI3K和AKT蛋白的表达及磷酸化情况。多组间比较采用单因素方差分析,组间两两比较采用LSD-t检验。 结果与DMSO组比较,除10 μg/mL补骨脂素作用24 h外,其余浓度补骨脂素作用不同时间的细胞存活率随着补骨脂素浓度增高、作用时间延长而逐渐降低(P < 0.05)。与DMSO组比较,30、100 μg/mL补骨脂素干预24 h后,G1期细胞比例增多,G2/M期比例减少,细胞凋亡率[(9.16±0.97)%、(15.45±1.57)%比(1.02±0.36)%]升高,划痕愈合率[24 h:(45.00±3.44)%、(27.60±2.21)%比(66.10±2.61)%,48 h:(70.00 ± 3.40)%、(45.17±2.44)%比(85.17±3.85)%]降低,PI3K、AKT mRNA表达以及PI3K、AKT蛋白表达水平和磷酸化水平均降低(P均< 0.05)。 结论补骨脂素降低膀胱癌细胞存活率、阻滞细胞周期、诱导细胞凋亡和抑制细胞迁移,其机制可能与下调PI3K、AKT mRNA、蛋白表达及磷酸化水平有关。

关 键 词:补骨脂素  抗肿瘤  膀胱癌  磷脂酰肌醇3-激酶  丝氨酸/苏氨酸激酶  
收稿时间:2022-01-26

Inhibitory effect and mechanisms of psoralen on proliferation and migration of bladder cancer T24 cells
Mingfang Weng,Rong Liu,Junjie Wei,Qin Lin,Xinghui Sun,dong Wang,Weizhen Wu. Inhibitory effect and mechanisms of psoralen on proliferation and migration of bladder cancer T24 cells[J]. , 2022, 12(4): 193-199. DOI: 10.3877/cma.j.issn.2095-1221.2022.04.001
Authors:Mingfang Weng  Rong Liu  Junjie Wei  Qin Lin  Xinghui Sun  dong Wang  Weizhen Wu
Affiliation:1. Department of Urology, 900th Hospital of Joint Logistics Support Force, Fuzhou 350025, China2. Department of Urology, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China
Abstract:ObjectiveTo investigate the effects of psoralen on the viability, cell cycle, apoptosis, and migration of human bladder cancer T24 cells and its mechanisms. MethodsBladder cancer cells were treated with cell culture medium, 3‰ dimethyl sulfoxide (DMSO) and different concentrations of psoralen and divided into normal control group, DMSO group and psoralen groups (10、30、50、100 μg/mL) . CCK-8 was used to detect cell viabilities. FACS was performed to detect cell cycles and apoptosis. Scratch tests were used to detecte the scratch healing rates. The expression levels of phosphatidylinositol-3-kinase (PI3K) and protein kinase B (AKT) mRNA were detected by RT-qPCR, and the expression and phosphorylation levels of PI3K and AKT protein were detected by Western blot. One-way ANOVA was used for comparison among multiple groups, and LSD-t test was used for comparison between groups. ResultsCompared with DMSO groups, the cell viabilities were decreased gradually with the increase of psoralen concentration and action time (P < 0.05) , except the cells were treated with 10 μg/mL psoralen for 24 h. Compared with DMSO group, the proportion of cells in G1 phase was increased after treatment with 30, 100 μg/mL psoralen for 24 h. The proportion of cells in G2/M phase was decreased, the apoptosis rates were increased [ (9.16±0.97) %、(15.45±1.57) % vs (1.02±0.36) %], the scratch healing rates were decreased [24 h: (45.00±3.44) %, (27.60± 2.21) %vs (66.10±2.61) %, 48 h: (70.00± 3.40) %, (45.17±2.44) %vs (85.17± 3.85) %], PI3K and AKT mRNA expression levels, protein expression levels and phosphorylation levels were all decreased (all P < 0.05) . ConclusionPsoralen decreased cell viability, blocked cell cycle, induced apoptosis and inhibited cell migration. Its mechanism may be that psoralen down-regulates the expression levels of PI3K and AKT mRNA and the expression levels and phosphorylation levels of PI3K and AKT protein.
Keywords:Psoralen  Antitumor  Bladder cancer  PI3K  AKT  
点击此处可从《中华细胞与干细胞杂志(电子版)》浏览原始摘要信息
点击此处可从《中华细胞与干细胞杂志(电子版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号